当前位置: X-MOL 学术Aust. J. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Synthesis of Norfijimycin A with Activity against Mycobacterium tuberculosis
Australian Journal of Chemistry ( IF 1.0 ) Pub Date : 2016-12-09 , DOI: 10.1071/ch16559
Alexander Stoye , Gayathri Nagalingam , Warwick J. Britton , Richard J. Payne

The total synthesis of norfijimycin A, a simplified analogue of the marine natural product fijimycin A, is described. Fijimycin A is a cyclic depsipeptide that has been shown to possess activity against methicillin-resistant Staphylococcus aureus. The natural product contains a rare N,β-dimethyl leucine unit with unknown stereochemistry at the β-carbon. To evaluate the importance of the β-methyl group for antimicrobial activity, we introduced N-methyl leucine into the natural product scaffold. The resulting norfijimycin A was shown to possess significant activity against Mycobacterium tuberculosis, the etiological agent of tuberculosis.



中文翻译:

具有抗结核分枝杆菌活性的诺非霉素A的合成

描述了海洋天然产物斐济霉素A的简化类似物诺非霉素A的全合成。斐济霉素A是一种环状二肽,已显示对耐甲氧西林的金黄色葡萄球菌具有活性。天然产物含有罕见的N,β-二甲基亮氨酸单元,在β-碳上的立体化学未知。为了评估β-甲基对抗菌活性的重要性,我们将N-甲基亮氨酸引入了天然产物支架中。所得的诺非霉素A显示出对结核分枝杆菌(结核分枝杆菌)具有显着的活性。

更新日期:2016-12-09
down
wechat
bug